VIA Disc NP Registry 3.0

Description

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Conditions

Discogenic Pain, Back Pain, Back Pain, Low

Talk to us

Study Overview

On this page

Study Details

Study overview

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

VIA Disc NP Registry 3.0

VIA Disc NP Registry 3.0

Condition
Discogenic Pain
Intervention / Treatment

-

Contacts and Locations

Little Rock

Mocek Spine, Little Rock, Arkansas, United States, 72205

Englewood

MD Pain, Englewood, Colorado, United States, 80112

Grand Junction

Western Rockies Interventional Pain, Grand Junction, Colorado, United States, 81505

Greenwood Village

The Denver Spine & Pain Institute, Greenwood Village, Colorado, United States, 80111

Thornton

Premier Spine and Pain Institute, Thornton, Colorado, United States, 80229

Gainesville

The Orthopedic Institute, Gainesville, Florida, United States, 32605

Jupiter

Raso Pain Center, Jupiter, Florida, United States, 33477

West Palm Beach

Interventional Spine Care of the Palm Beaches, West Palm Beach, Florida, United States, 33407

Jasper

Horizon Clinical Research, Jasper, Georgia, United States, 30143

Fishers

The Orthopedic Research Foundation, Inc., Fishers, Indiana, United States, 46278

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
  • 2. 18 years of age or older
  • 3. Literate, able to speak and read English, and able to complete questionnaires independently
  • 4. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.
  • 1. Participant did not receive VIA Disc NP injection
  • 2. Participant is pregnant (self-reported, no special study pregnancy testing needed).
  • 3. Any contraindications as noted in the VIA Disc NP Instructions for Use
  • 4. Previous treatment with VIA Disc NP

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

VIVEX Biologics, Inc.,

Jasmine Wilson, STUDY_DIRECTOR, cro

Study Record Dates

2027-01-01